Accendra Health, Inc. ACH
At closeNov 4, 2026, 6:23 AM EST
Pre-market · Nov 4, 6:23 AM ET
- YTD
- -89.90%
- 1 year
- -91.80%
- Market cap
- 21.75M
- Revenue (ttm)
- 10.77B
- Profit margin
- -12.45%
- EPS (ttm)
- -1.55
- Forward P/E
- 2.40
- YTD return
- -89.90%
- 1-year return
- -91.80%
- Volume
- 3.73M
- Avg volume
- 2.45M
- Open
- 0.28
- Previous close
- 0.2635
- Day's range
- 0.2459 – 0.2898
- 52-week range
- 0.19 – 4.69
- Beta
- 1.36
- Analysts
- Hold
- Price target
- 5.44 (+1823.6%)
- Earnings date
- Dec 25, 2024
2Y -11.7172 (-97.64%)
Key statistics
- Enterprise value
- 2.43B
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 1.50%
- Free cash flow
- 309.35M
- Total cash
- 32.84M
- Total debt
- 2.24B
- Return on equity
- -196.39%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: hold
- Target (low)
- 4.00
- Target (mean)
- 5.44
- Target (high)
- 7.00
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell2
Next earnings
Dec 25, 2024
Expected Dec 25, 2024. Consensus EPS estimate 0.22235.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 25, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 1, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 2, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Oct 25, 2023 | Sep 1, 2023 | 0.00 | 0.38 | — | — |
| Aug 22, 2023 | Jun 1, 2023 | 0.00 | 0.33 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2025 | UBS | down | Buy | Neutral |
| Aug 27, 2025 | JP Morgan | main | Underweight | Underweight |
| Aug 13, 2025 | UBS | main | Buy | Buy |
| Aug 12, 2025 | Baird | main | Outperform | Outperform |
| Aug 12, 2025 | Citigroup | main | Buy | Buy |
| Aug 12, 2025 | B of A Securities | main | Underperform | Underperform |
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
- Country
- United States
- Website
- owens-minor.com
News
12 Health Care Stocks Moving In Monday's After-Market Session 
Accendra Health Extends $150M Receivables Purchase Agreement To October 2029 With Its Size Unchanged 
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029 
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on ACH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK MARK A. | Director | Stock Award(Grant) | May 14, 2025 | 40,068 |
| COLISEUM CAPITAL MANAGEMENT, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 13, 2025 | 0 |
| GARDNER-SMITH KENNETH | Director | Stock Award(Grant) | May 14, 2025 | 54,922 |
| HENKEL ROBERT J | Director | Stock Award(Grant) | May 14, 2025 | 77,412 |
| JOHNSON-MILLS RITA | Director | Stock Award(Grant) | May 14, 2025 | 54,125 |
| KLEMASH STEPHEN W. | Director | Stock Award(Grant) | May 14, 2025 | 59,051 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Coliseum Capital Management, Llc | 16.94% | 13,100,807 | 30.40M | Sep 29, 2025 |
| Vanguard Group Inc | 7.71% | 5,962,847 | 13.83M | Sep 29, 2025 |
| Blackrock Inc. | 7.26% | 5,613,838 | 13.02M | Sep 29, 2025 |
| Dimensional Fund Advisors LP | 4.53% | 3,507,559 | 8.14M | Sep 29, 2025 |
| Millennium Management Llc | 4.22% | 3,261,254 | 7.57M | Sep 29, 2025 |
| Charles Schwab Investment Management, Inc. | 4.15% | 3,208,915 | 7.45M | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 2,329,191 | 5.40M | Sep 29, 2025 |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 2.48% | 1,915,548 | 4.44M | Aug 30, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.44% | 1,885,997 | 4.38M | Sep 29, 2025 |
| NORTHERN LIGHTS FUND TRUST II-Invenomic Fund | 1.67% | 1,293,892 | 3.00M | Oct 30, 2025 |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 1.45% | 1,120,187 | 2.60M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07% | 824,626 | 1.91M | Sep 29, 2025 |